BBNX
Beta Bionics, Inc.$17.50+0.07 (+0.37%)Prev Close$17.43·MCap$853.0M·P/E—·Vol378.3K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
41
$5.79M
◆
Net Activity
Net Seller
$5.79M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Beta Bionics, Inc. (BBNX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 41 insider sales totaling $5.79M. The most recent insider transaction was by Hopman Mark (officer: Chief Commercial Officer), who sold $7.0K worth of shares on Oct 5, 2026. Beta Bionics, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $853.0M.
BBNX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 370 | $18.96 | $7.0K | 56,109 |
| Sep 23, 2026 | Jones Christy | director | Sell | 6,430 | $23.00 | $147.9K | 19,564 |
| Sep 18, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 35,994 | $18.46 | $664.5K | 88,033-29% |
| Sep 17, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 30,779 | $20.13 | $619.6K | 56,479-35% |
| Sep 17, 2026 | Mensinger Mike | officer: Chief Product Officer | Sell | 2,650 | $22.00 | $58.3K | 177,390 |
| Sep 15, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 775 | $15.52 | $12.0K | 86,382 |
| Sep 10, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 36,870 | $18.46 | $680.7K | 87,157-30% |
| Sep 4, 2026 | Saint Sean | director, officer: President & CEO | Sell | 5,641 | $20.08 | $113.3K | 398,429 |
| Sep 3, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 5,327 | $19.11 | $101.8K | 124,027 |
| Sep 3, 2026 | Feider Stephen | officer: Chief Financial Officer | Sell | 6,675 | $19.11 | $127.6K | 159,378 |
| Sep 3, 2026 | Mensinger Mike | officer: Chief Product Officer | Sell | 4,375 | $19.11 | $83.6K | 180,040 |
| Sep 3, 2026 | Saint Sean | director, officer: President & CEO | Sell | 16,867 | $19.11 | $322.4K | 404,070 |
| Sep 3, 2026 | Russell Steven Jon | officer: Chief Medical Officer | Sell | 4,221 | $19.11 | $80.7K | 169,628 |
| Jun 30, 2026 | Feider Stephen | officer: Chief Financial Officer | Sell | 10,000 | $17.04 | $170.4K | 165,931 |
| Jun 25, 2026 | Jones Christy | director | Sell | 1,406 | $15.00 | $21.1K | 25,994 |
| Jun 25, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 1,258 | $15.01 | $18.9K | 129,354 |
| Jun 5, 2026 | Jones Christy | director | Sell | 2,811 | $14.00 | $39.4K | 27,400 |
| Jun 5, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 275 | $12.31 | $3.4K | 130,612 |
| Jun 3, 2026 | Saint Sean | director, officer: President & CEO | Sell | 16,872 | $12.61 | $212.7K | 420,937 |
| Jun 3, 2026 | Mensinger Mike | officer: Chief Product Officer | Sell | 4,378 | $12.61 | $55.2K | 184,415 |
| Jun 3, 2026 | Russell Steven Jon | officer: Chief Medical Officer | Sell | 4,222 | $12.61 | $53.2K | 173,849 |
| Jun 3, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 5,329 | $12.61 | $67.2K | 130,887 |
| Jun 3, 2026 | Feider Stephen | officer: Chief Financial Officer | Sell | 6,676 | $12.61 | $84.2K | 166,053 |
| May 26, 2026 | Jones Christy | director | Sell | 1,998 | $9.95 | $19.9K | 13,246 |
| May 26, 2026 | Lezack Adam | director | Sell | 1,000 | $9.95 | $9.9K | 11,432 |
| Mar 16, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 2,917 | $30.27 | $88.3K | 138,277 |
| Mar 16, 2026 | Russell Steven Jon | officer: Chief Medical Officer | Sell | 1,025 | $29.34 | $30.1K | 178,071 |
| Mar 5, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 353 | $11.57 | $4.1K | 139,133 |
| Jan 7, 2026 | Mensinger Mike | officer: Chief Product Officer | Sell | 2,200 | $30.10 | $66.2K | 80,752 |
| Jan 6, 2026 | Mensinger Mike | Chief Product Officer | Sell | 2,200 | $30.10 | $66.2K | 0 |
| Jan 5, 2026 | Feider Stephen | officer: Chief Financial Officer | Sell | 20,000 | $29.53 | $590.7K | 42,614-32% |
| Jan 5, 2026 | Mensinger Mike | officer: Chief Product Officer | Sell | 600 | $30.20 | $18.1K | 82,952 |
| Jan 2, 2026 | Feider Stephen | Chief Financial Officer | Sell | 20,000 | $29.53 | $590.7K | 0 |
| Jan 2, 2026 | Mensinger Mike | Chief Product Officer | Sell | 7,800 | $29.61 | $230.9K | 0 |
| Dec 2, 2025 | Feider Stephen | Chief Financial Officer | Sell | 1,427 | $29.34 | $41.9K | 0 |
| Dec 2, 2025 | Mensinger Mike | Chief Product Officer | Sell | 1,063 | $29.34 | $31.2K | 0 |
| Dec 2, 2025 | Saint Sean | President & CEO | Sell | 3,278 | $29.34 | $96.2K | 0 |
| Dec 1, 2025 | Lezack Adam | Director | Sell | 1,406 | $29.55 | $41.5K | 0 |
| Dec 1, 2025 | Palasis Maria | Director | Sell | 1,406 | $29.55 | $41.6K | 0 |
| Oct 31, 2025 | Lezack Adam | Director | Sell | 1,406 | $26.87 | $37.8K | 0 |
| Oct 31, 2025 | Palasis Maria | Director | Sell | 1,406 | $26.91 | $37.8K | 0 |
| Oct 3, 2025 | Feider Stephen | Chief Financial Officer | Sell | 4,982 | $21.69 | $108.1K | 0 |
| Oct 1, 2025 | Feider Stephen | Chief Financial Officer | Sell | 15,018 | $20.76 | $311.8K | 0 |
| Sep 8, 2025 | Feider Stephen | Chief Financial Officer | Sell | 9,900 | $21.13 | $209.2K | 0 |
| Sep 5, 2025 | Feider Stephen | Chief Financial Officer | Sell | 100 | $21.00 | $2.1K | 0 |
| Sep 4, 2025 | Hopman Mark | Chief Commercial Officer | Sell | 18,229 | $20.34 | $370.8K | 0 |
| Sep 2, 2025 | Feider Stephen | Chief Financial Officer | Sell | 1,462 | $18.86 | $27.6K | 0 |
| Sep 2, 2025 | Hopman Mark | Chief Commercial Officer | Sell | 848 | $18.86 | $16.0K | 0 |
| Sep 2, 2025 | Mensinger Mike | Chief Product Officer | Sell | 1,089 | $18.86 | $20.5K | 0 |
| Sep 2, 2025 | Russell Steven Jon | Chief Medical Officer | Sell | 1,015 | $18.86 | $19.1K | 0 |
Showing 1–50 of 61
1 / 2
BBNX Insider Buying Activity
The following table shows recent insider purchases of Beta Bionics, Inc. (BBNX) stock reported via SEC Form 4 filings.
No insider buying activity found for BBNX in the last 12 months.
BBNX Insider Selling Activity
The following table shows recent insider sales of Beta Bionics, Inc. (BBNX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 370 | $18.96 | $7.0K | 56,109 |
| Sep 23, 2026 | Jones Christy | director | Sell | 6,430 | $23.00 | $147.9K | 19,564 |
| Sep 18, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 35,994 | $18.46 | $664.5K | 88,033-29% |
| Sep 17, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 30,779 | $20.13 | $619.6K | 56,479-35% |
| Sep 17, 2026 | Mensinger Mike | officer: Chief Product Officer | Sell | 2,650 | $22.00 | $58.3K | 177,390 |
| Sep 15, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 775 | $15.52 | $12.0K | 86,382 |
| Sep 10, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 36,870 | $18.46 | $680.7K | 87,157-30% |
| Sep 4, 2026 | Saint Sean | director, officer: President & CEO | Sell | 5,641 | $20.08 | $113.3K | 398,429 |
| Sep 3, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 5,327 | $19.11 | $101.8K | 124,027 |
| Sep 3, 2026 | Feider Stephen | officer: Chief Financial Officer | Sell | 6,675 | $19.11 | $127.6K | 159,378 |
| Sep 3, 2026 | Mensinger Mike | officer: Chief Product Officer | Sell | 4,375 | $19.11 | $83.6K | 180,040 |
| Sep 3, 2026 | Saint Sean | director, officer: President & CEO | Sell | 16,867 | $19.11 | $322.4K | 404,070 |
| Sep 3, 2026 | Russell Steven Jon | officer: Chief Medical Officer | Sell | 4,221 | $19.11 | $80.7K | 169,628 |
| Jun 30, 2026 | Feider Stephen | officer: Chief Financial Officer | Sell | 10,000 | $17.04 | $170.4K | 165,931 |
| Jun 25, 2026 | Jones Christy | director | Sell | 1,406 | $15.00 | $21.1K | 25,994 |
| Jun 25, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 1,258 | $15.01 | $18.9K | 129,354 |
| Jun 5, 2026 | Jones Christy | director | Sell | 2,811 | $14.00 | $39.4K | 27,400 |
| Jun 5, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 275 | $12.31 | $3.4K | 130,612 |
| Jun 3, 2026 | Saint Sean | director, officer: President & CEO | Sell | 16,872 | $12.61 | $212.7K | 420,937 |
| Jun 3, 2026 | Mensinger Mike | officer: Chief Product Officer | Sell | 4,378 | $12.61 | $55.2K | 184,415 |
| Jun 3, 2026 | Russell Steven Jon | officer: Chief Medical Officer | Sell | 4,222 | $12.61 | $53.2K | 173,849 |
| Jun 3, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 5,329 | $12.61 | $67.2K | 130,887 |
| Jun 3, 2026 | Feider Stephen | officer: Chief Financial Officer | Sell | 6,676 | $12.61 | $84.2K | 166,053 |
| May 26, 2026 | Jones Christy | director | Sell | 1,998 | $9.95 | $19.9K | 13,246 |
| May 26, 2026 | Lezack Adam | director | Sell | 1,000 | $9.95 | $9.9K | 11,432 |
| Mar 16, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 2,917 | $30.27 | $88.3K | 138,277 |
| Mar 16, 2026 | Russell Steven Jon | officer: Chief Medical Officer | Sell | 1,025 | $29.34 | $30.1K | 178,071 |
| Mar 5, 2026 | Hopman Mark | officer: Chief Commercial Officer | Sell | 353 | $11.57 | $4.1K | 139,133 |
| Jan 7, 2026 | Mensinger Mike | officer: Chief Product Officer | Sell | 2,200 | $30.10 | $66.2K | 80,752 |
| Jan 6, 2026 | Mensinger Mike | Chief Product Officer | Sell | 2,200 | $30.10 | $66.2K | 0 |
| Jan 5, 2026 | Feider Stephen | officer: Chief Financial Officer | Sell | 20,000 | $29.53 | $590.7K | 42,614-32% |
| Jan 5, 2026 | Mensinger Mike | officer: Chief Product Officer | Sell | 600 | $30.20 | $18.1K | 82,952 |
| Jan 2, 2026 | Feider Stephen | Chief Financial Officer | Sell | 20,000 | $29.53 | $590.7K | 0 |
| Jan 2, 2026 | Mensinger Mike | Chief Product Officer | Sell | 7,800 | $29.61 | $230.9K | 0 |
| Dec 2, 2025 | Feider Stephen | Chief Financial Officer | Sell | 1,427 | $29.34 | $41.9K | 0 |
| Dec 2, 2025 | Mensinger Mike | Chief Product Officer | Sell | 1,063 | $29.34 | $31.2K | 0 |
| Dec 2, 2025 | Saint Sean | President & CEO | Sell | 3,278 | $29.34 | $96.2K | 0 |
| Dec 1, 2025 | Lezack Adam | Director | Sell | 1,406 | $29.55 | $41.5K | 0 |
| Dec 1, 2025 | Palasis Maria | Director | Sell | 1,406 | $29.55 | $41.6K | 0 |
| Oct 31, 2025 | Lezack Adam | Director | Sell | 1,406 | $26.87 | $37.8K | 0 |
| Oct 31, 2025 | Palasis Maria | Director | Sell | 1,406 | $26.91 | $37.8K | 0 |
| Oct 3, 2025 | Feider Stephen | Chief Financial Officer | Sell | 4,982 | $21.69 | $108.1K | 0 |
| Oct 1, 2025 | Feider Stephen | Chief Financial Officer | Sell | 15,018 | $20.76 | $311.8K | 0 |
| Sep 8, 2025 | Feider Stephen | Chief Financial Officer | Sell | 9,900 | $21.13 | $209.2K | 0 |
| Sep 5, 2025 | Feider Stephen | Chief Financial Officer | Sell | 100 | $21.00 | $2.1K | 0 |
| Sep 4, 2025 | Hopman Mark | Chief Commercial Officer | Sell | 18,229 | $20.34 | $370.8K | 0 |
| Sep 2, 2025 | Feider Stephen | Chief Financial Officer | Sell | 1,462 | $18.86 | $27.6K | 0 |
| Sep 2, 2025 | Hopman Mark | Chief Commercial Officer | Sell | 848 | $18.86 | $16.0K | 0 |
| Sep 2, 2025 | Mensinger Mike | Chief Product Officer | Sell | 1,089 | $18.86 | $20.5K | 0 |
| Sep 2, 2025 | Russell Steven Jon | Chief Medical Officer | Sell | 1,015 | $18.86 | $19.1K | 0 |
BBNX Insiders
Similar Stocks to BBNX
SYK
Stryker Corporation
$277.41+0.16%
$105.59B
BSX
Boston Scientific Corporation
$42.55+1.21%
$63.32B
EW
Edwards Lifesciences Corporation
$84.67+0.52%
$49.03B
DXCM
DexCom, Inc.
$84.08-0.39%
$32.21B
ZBH
Zimmer Biomet Holdings, Inc.
$89.49+0.74%
$17.72B
GMED
Globus Medical, Inc.
$75.06+2.37%
$10.31B
GKOS
Glaukos Corporation
$165.55+2.51%
$9.53B
PODD
Insulet Corp.
$135.02+0.43%
$9.33B